Skip to main content

Main menu

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021
  • Other Publications
    • www.clevelandclinic.org

User menu

  • Register
  • Log in

Search

  • Advanced search
Cleveland Clinic Journal of Medicine
  • Other Publications
    • www.clevelandclinic.org
  • Register
  • Log in
Cleveland Clinic Journal of Medicine

Advanced Search

  • Home
  • Content
    • Current Issue
    • Ahead of Print
    • Past Issues
    • Supplements
    • Article Type
  • Specialty
    • Articles by Specialty
  • CME/MOC
    • Articles
    • Calendar
  • Info For
    • Manuscript Submission
    • Authors & Reviewers
    • Subscriptions
    • About CCJM
    • Contact Us
    • Media Kit
  • Conversations with Leaders
  • Conference Coverage
    • CHEST 2021
    • IDWeek 2021
    • IAS 2021
    • ADA 2021
    • ATS 2021
    • ACC 2021
    • ACP 2021
    • AAN 2021

Table of Contents

April 01, 2002; Volume 69,Issue 4 suppl 2

Proceedings of the 10th International Vasculitis and ANCA Workshop

Pathogenesis

  • You have access
    Induction of Pauci-Immune Necrotizing and Crescen-Tic Glomerulonephritis (NCGN) by Intravenous Administration of Anti-Myeloperoxidase (Anti-MPO) Antibodies to Recombinase Activating Gene-2 Deficient (Rag-2 -/-) Mice
    JC Jennette,, H Xiao,, P Heeringa,, Z Liu,, P Hu,, M Zhao,, Y Aratani, and RJ Falk,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-13;
  • You have access
    Induction of Necrotizing and Crescentic Glomeru-Lonephritis (NCGN) and Small-Vessel Vasculitis (SVV) by Adoptive Transfer of Anti-Myeloperoxidase (Anti-MPO) Lymphocytes into Recombinase Activating Gene-2 Deficient (Rag-2 -/-) Mice
    H Xiao,, P Heeringa,, Z Liu,, P Hu,, M Zhao,, Y Aratani,, RJ Falk, and JC Jennette,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-13;
  • You have access
    Contribution of Activated Neutrophils and Mpo-Anca to the Development of Crescentic Glomeru-Lonephritis in Scg/Kj Mice
    A Ishida-Okawara,, T Ito-Ihara,, T Ono,, E Muso,, K Saiga,, K Nemoto, and K Suzuki,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-13-SII-14;
  • You have access
    Known infectious causes of vasculitis in man
    Stanley J. Naides, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-15-SII-19;
  • You have access
    HCV and cryoglobulinemic vasculitis
    C. Ferri, MD, A.L. Zignego, MD, D. Giuggioli, MD, M. Sebastiani, MD, M. Cazzato, MD, A. Antonelli, MD, L. La Civita, MD, P. Fadda, MD, G. Longombardo, BS and S. Pileri, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-20-SII-23;
  • You have access
    Infections in primary vasculitides
    J.W. Cohen Tervaert, MD, PhD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-24-SII-26;
  • You have access
    Staphylococcal Toxic-Shock-Syndrome-Toxin-1 (TSSt-1) is a Risk Factor for Disease Relapse in Wegener’s Granulomatosis
    ER Popa,, B van der Meer,, J Arends,, WM Manson,, NA Bos,, CGM Kallenberg,, JW Cohen Tervaert, and CA Stegeman,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-27;
  • You have access
    Chlamydia Pneumoniae and Giant-Cell Arteritis: Failure to Detect Chlamydia Pneumoniae in Temporal Artery Biopsies by Polymerase Chain Reaction in 90 Cases and 90 Controls
    MJ Regan,, BJ Wood,, Y-H Hsieh,, ML Theodore,, TC Quinn,, DB Hellmann,, WR Green,, CA Gaydos, and JH Stone,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-27;
  • You have access
    Pathogenic mechanisms in giant cell arteritis
    Cornelia M. Weyand, MD and Jörg J. Goronzy, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-28-SII-32;
  • You have access
    Implications for pathogenesis of patterns of injury in small- and medium-sized-vessel vasculitis
    J. Charles Jennette, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-33-SII-38;
  • You have access
    Superantigenic Activation of T Lymphocytes and Endothelial Cells: A Mechanism for Superantigen-Induced Vasculitis
    PA Brogan,, V Shah,, N Klein, and MJ Dillon,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-39;
  • You have access
    Analysis of Autoantibody Repertoires in Small and Medium Sized Vessel Vasculitis: Evidence for Disease-Specific Perturbations in Classic Polyarteritis Nodosa (PAN), Micropolyangiitis (MPA), Churg-Strauss Syndrome (CSS) and Wegener’s Granulomatosis (WG)
    Y Chanseaud,, L Guillevin,, M Kambouchner,, MC Boissier, and L Mouthon,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-39;
  • You have access
    Granuloma formation, implications for the pathogenesis of vasculitis
    Michael C. Sneller, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-40-SII-43;
  • You have access
    Chemokine Receptor Expression on CD4+ and CD8+ Memory T-Cells and in Granulomas in Wegener’s Granulomatosis
    P Lamprecht,, A Erdmann,, A Mueller,, E Csernok,, H Bruehl,, WL Gross, and M Mack,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-44;
  • You have access
    Genetic Resistance to Wegener’s Granulomatosis—A Role for CCR5 in Patients Without Antineutrophil Cytoplasmic Antibodies
    Y Zhou,, D Huang,, C Farver, and G Hoffman,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-44;
  • You have access
    Endothelial cell biology, perivascular inflammation, and vasculitis
    Maria C. Cid, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-45-SII-49;
  • You have access
    Novel Effects of Inflammatory Cell Proteases on Vascular Endothelia
    GA Preston,, WF Pendergraft,, JJ Yang,, JC Jennette, and RJ Falk,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-50;
  • You have access
    Understanding the pathogenesis of ANCA: Where are we today?
    Gloria A. Preston, PhD, Jia Jin Yang, MD, Hong Xiao, MD and Ronald J. Falk, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-51-SII-54;
  • You have access
    TNF-α-Accelerated Apoptosis Abrogates Anca-Mediated Neutrophil Respiratory Burst by a Caspase-Dependent Mechanism
    R Kettritz,, J Scheumann,, Y Xu,, FC Luft, and H Haller,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-55;
  • You have access
    Membrane Expression of Neutrophil Proteinase 3 (Pr3) Is Associated With Relapse in Pr3-Anca Related Vasculitis
    AA Rarok,, CA Stegeman,, PC Limburg, and CGM Kallenberg,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-55;
  • You have access
    ANCA subsets: Influence on disease phenotype
    Ulrich Specks, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-56-SII-59;
  • You have access
    Sequential Epitope Mapping of the Myeloperoxidase Antigen
    DM Wynn, and JA James,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-60;
  • You have access
    Genetics of ANCA-associated vasculitides
    Cees G.M. Kallenberg, MD, PhD, Agnieszka Rarok, BSc and Coen A. Stegeman, MD, PhD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-61-SII-63;
  • You have access
    Membrane Expression of Proteinase 3 is Genetically Controlled
    A Schreiber,, A Busjahn,, FC Luft, and R Kettritz,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-64;
  • You have access
    Genetic Polymorphisms in TNF, IL-1, IL-6 And Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Wegener’s Granulomatosis (WG)
    Y Zhou,, D Huang, and GS Hoffman,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-64;
  • You have access
    Classification of anti–endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications
    Yehuda Shoenfeld, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-65-SII-66;
  • You have access
    HMG-CoA Reductase Inhibitors Decrease Anca-Mediated Activation Of Human Neutrophils
    M Choi,, S Rolle,, M Rane,, H Haller,, FC Luft, and R Kettritz,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-68;
  • You have access
    Host and viral genes that control herpesvirus vasculitis
    Herbert W. Virgin, MD, PhD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-7-SII-12;

Epidemiology of Vasculitis

  • You have access
    Kawasaki disease: Etiology, pathogenesis, and treatment
    Karyl S. Barron, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-69-SII-78;
  • You have access
    Epidemiology of giant-cell arteritis
    Gene G. Hunder, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-79-SII-82;
  • You have access
    Ethnic Disparity in the Incidence of Temporal Arteri-Tis: a 32-Year Experience at an Urban Medical Center
    MJ Regan,, WR Green, and JH Stone,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-83;
  • You have access
    Epidemiology of Wegener’s granulomatosis, microscopic polyangiitis, and Churg-Strauss syndrome
    Richard A. Watts, DM, FRCP, David G.I. Scott, MD, FRCP and Suzanne E. Lane, MB, MRCP
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-84;
  • You have access
    Epidemiology of Henoch-Schönlein purpura
    Frank T. Saulsbury, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-87;
  • You have access
    Henoch-Schönlein Purpura and Cutaneous Leukocy-Toclastic Angiitis Exhibit Different HLA-DRB1 Associations
    MM Amoli,, W Thomson,, AH Hajeer,, MC Calviño,, C Garcia-Porrua,, WER Ollier, and MA Gonzalez-Gay,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-90;

Diagnostic Modalities, Surrogate Markers of Disease Activity, and Tools for Outcome Measurements

  • You have access
    Cytokines in giant-cell arteritis
    Jörg J. Goronzy, MD, PhD and Cornelia M. Weyand, MD, PhD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-91-SII-94;
  • You have access
    Utility of imaging studies in assessment of vascular inflammation
    Daniël Blockmans, MD, PhD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-95-SII-99;
  • You have access
    Measuring disease activity and outcomes in clinical studies
    Raashid Luqmani, DM, FRCP (Edin)
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-100-SII-102;
  • You have access
    Increases of PR3 and MPO Gene Transcription in Circulating Leukocyte of Anca-Associated Disease Correlate with Disease Activity
    JJ Yang,, GA Preston,, DA Alcorta,, BD Phillips,, RP Thomas,, SL Hogan,, JC Jennette, and RJ Falk,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-103;
  • You have access
    Cardiac Involvement in Wegener’s Granulomatosis: Echocardiographic Features and Clinical Outcomes
    GHM Oliveira,, JB Seward, and U Specks,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-103;
  • You have access
    Endothelial Microparticles: Just Blood “Dust,” or a “Must” for the Diagnosis and Monitoring of Disease Activity in Childhood Vasculitides?
    PA Brogan,, V Shah,, C Brachet,, N Klein, and MJ Dillon,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-103-SII-104;
  • You have access
    Diagnostic strategies in vasculitis affecting the central nervous system
    Leonard H. Calabrese, DO
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-105-SII-108;
  • You have access
    Circulating Endothelial Cells and Vasculitis
    A Woywodt,, F Streiber,, K de Groot,, H Haller, and M Haubitz,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-109;
  • You have access
    Diffuse Endothelial Dysfunction is a Common Feature of SNV
    PA Bacon,, RJ Stevens,, DM Carruthers,, AD Diler,, K Raza, and J Townend,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-109;

Treatment and Outcomes

  • You have access
    Conventional treatment and outcome of Wegener’s granulomatosis and microscopic polyangiitis
    David R.W. Jayne, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-110-SII-115;
  • You have access
    Randomized Trial of Cyclophosphamide Versus Methotrexate for Induction of Remission in “Non-Renal” Anca-Associated Vasculitis
    K de Groot,, N Rasmussen,, JW Cohen Tervaert,, DRW Jayne, and ,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-116;
  • You have access
    Treatment of giant-cell arteritis: where we have been and why we must move on
    Gary S. Hoffman, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII117-SII120;
  • You have access
    Henoch-Schönlein purpura (treatment and outcome)
    Michael J. Dillon, FRCP, FRCPCH
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-121-SII-123;
  • You have access
    Targeted therapies in systemic vasculitis
    John H. Stone, MD, MPH
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-124-SII-128;
  • You have access
    Campath 1-H (Anti-CD52) for Refractory Vasculitis: Retrospective Cambridge Experience 1989–1999
    DRW Jayne,
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-129;

Treating the Permanent Sequelae of Vasculitis

  • You have access
    Inflammation in acute coronary syndromes
    Mark Robbins, MD and Eric J. Topol, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-130-SII-142;
  • You have access
    Kidney transplantation and ANCA-associated vasculitis
    F. J. van der Woude, MD, PHD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-143-SII-145;
  • You have access
    Surgical treatment of Takayasu’s disease
    Joseph M. Giordano, MD, FACS
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-146-SII-148;
  • You have access
    New approaches to the management of subglottic stenosis in Wegener’s granulomatosis
    Isaac Eliachar, MD, James Chan, MD and Lee Akst, MD
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-149-SII-151;
  • You have access
    Sinonasal complications of vasculitic diseases
    Robert S. Lebovics, MD, FACS
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-152-SII-154;

Poster Presentations

  • You have access
    Pathogenesis—Immune Predisposition and Infectious Etiology of Systemic Vasculitis
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-155-SII-157;
  • You have access
    Pathogenesis—Patterns of Injury: Implications for Pathogenesis
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-157-SII-159;
  • You have access
    Pathogenesis—Possible Role of ANCA and AECA in Selected Forms of Systemic Vasculitis
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-160-SII-165;
  • You have access
    Epidemiology of Vasculitis
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-165-SII-171;
  • You have access
    Diagnostic Modalities, Surrogate Markers of Disease Activity, and Tools for Outcome Measurements
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-171-SII-179;
  • You have access
    Treatment and Outcomes
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-179-SII-191;
  • You have access
    Treating the Permanent Sequelae of Vasculitis
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-191-SII-192;

Author Index

  • You have access
    Author Index
    Cleveland Clinic Journal of Medicine April 2002, 69 (4 suppl 2) SII-193-SII-196;
Back to top
PreviousNext

In this issue

Cleveland Clinic Journal of Medicine: 69 (4 suppl 2)
Cleveland Clinic Journal of Medicine
Vol. 69, Issue 4 suppl 2
1 Apr 2002
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
Sign up for alerts

Jump to

  • Pathogenesis
  • Epidemiology of Vasculitis
  • Diagnostic Modalities, Surrogate Markers of Disease Activity, and Tools for Outcome Measurements
  • Treatment and Outcomes
  • Treating the Permanent Sequelae of Vasculitis
  • Poster Presentations
  • Author Index
  • Editor's Picks
  • Most Cited
  • Most Read
Loading
Which ICU patients need stress ulcer prophylaxis?
Dactylitis from Mycobacterium intracellulare infection
Mondor disease of the breast
Dyspnea and cough in a lung transplant recipient
Atypical erythema as a clinical presentation of tinea incognito
Pigmented lesion on nail bed: Pseudo-Hutchinson sign
Hampton hump in acute pulmonary embolism
A brownish erythematous patch in the nipple-areola complex
The underappreciated role of documentation in improving COPD care
Oral hyperpigmentation with weakness and salt-craving
Glycemic targets in the ICU: A look back, and ahead
Unilateral pulmonary edema
Does my patient need an allergy evaluation for penicillin allergy?

Navigate

  • Current Issue
  • Past Issues
  • Supplements
  • Article Type
  • Specialty
  • CME/MOC Articles
  • CME/MOC Calendar
  • Media Kit

Authors & Reviewers

  • Manuscript Submission
  • Authors & Reviewers
  • Subscriptions
  • About CCJM
  • Contact Us
  • Cleveland Clinic Center for Continuing Education
  • Consult QD

Share your suggestions!

Copyright © 2022 The Cleveland Clinic Foundation. All rights reserved. The information provided is for educational purposes only. Use of this website is subject to the website terms of use and privacy policy. 

Powered by HighWire